Research ArticleParkinson’s Disease

Preclinical and clinical assessment of inhaled levodopa for OFF episodes in Parkinson’s disease

See allHide authors and affiliations

Science Translational Medicine  12 Oct 2016:
Vol. 8, Issue 360, pp. 360ra136
DOI: 10.1126/scitranslmed.aad8858

Article Information

vol. 8 no. 360 360ra136

PubMed: 
Print ISSN: 
Online ISSN: 
History: 
  • Received for publication November 16, 2015
  • Accepted for publication July 31, 2016
  • .

Author Information

  1. Michael M. Lipp1,*,
  2. Richard Batycky1,
  3. Jerome Moore2,
  4. Mika Leinonen3 and
  5. Martin I. Freed1,
  1. 1Acorda Therapeutics, Chelsea, MA 02150, USA.
  2. 2Pacific BioDevelopment, LLC, Emeryville, CA 94608, USA.
  3. 34Pharma AB, Stockholm, Sweden.
  1. *Corresponding author. Email: mlipp{at}acorda.com
  • At the time of the study, M.I.F. was employed by Civitas Therapeutics (now wholly owned by Acorda Therapeutics).

Altmetric

Article usage

Article usage: October 2016 to June 2021

AbstractFullPdf
Oct 20165277857862
Nov 20163923852
Dec 20162041922
Jan 20171482420
Feb 20171172623
Mar 2017842815
Apr 20171153135
May 2017100279
Jun 2017851514
Jul 20175795
Aug 2017892321
Sep 2017991514
Oct 20171061511
Nov 201772123
Dec 2017801511
Jan 201857106
Feb 20184567
Mar 201876139
Apr 20187886
May 2018112148
Jun 2018891511
Jul 2018991719
Aug 2018601110
Sep 201859177
Oct 2018621514
Nov 201851349
Dec 2018961614
Jan 2019861715
Feb 2019681513
Mar 2019561713
Apr 2019281921
May 2019671813
Jun 2019671542
Jul 2019701716
Aug 2019551419
Sep 2019391312
Oct 2019681322
Nov 20193637
Dec 201946520
Jan 2020411614
Feb 202054914
Mar 202029108
Apr 2020571414
May 2020671637
Jun 202023747
Jul 20203882
Aug 20203465
Sep 202040712
Oct 202051358
Nov 202050113
Dec 2020401810
Jan 202175154
Feb 20214265
Mar 20215283
Apr 20211878
May 2021541011
Jun 202148453

Stay Connected to Science Translational Medicine